Literature DB >> 19318143

Recent advances in second-trimester abortion: an evidence-based review.

Cassing Hammond1.   

Abstract

The proportion of US abortions performed in the second trimester has varied little since 1992. Although 30 years of cumulative data corroborate the safety of dilation and evacuation (D&E), the most commonly used method of second-trimester abortion in the United States, both D&E and alternative induction regimens continue to evolve such that the traditional safety gap between medical and surgical regimens has narrowed. Providers now have options that allow them to either expedite D&E by diminishing the cervical-ripening period or reduce induction abortion intervals during medical induction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318143     DOI: 10.1016/j.ajog.2008.11.016

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.

Authors:  Karen Pazol; Andreea A Creanga; Suzanne B Zane
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

2.  Influence of Mifepristone in Induction Time for Terminations in the Second and Third Trimester.

Authors:  M Hoopmann; J Hirneth; J Pauluschke-Fröhlich; B Yazdi; H Abele; D Wallwiener; K O Kagan
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03-28       Impact factor: 2.915

3.  Second-trimester abortion attitudes and practices among maternal-fetal medicine and family planning subspecialists.

Authors:  J L Kerns; J K Turk; C M Corbetta-Rastelli; M G Rosenstein; A B Caughey; J E Steinauer
Journal:  BMC Womens Health       Date:  2020-02-03       Impact factor: 2.809

4.  Leukocytosis during cervical preparation with osmotic dilators for dilation and evacuation.

Authors:  Lyndsey S Benson; Jordan Stevens; Elizabeth A Micks; Sarah W Prager
Journal:  SAGE Open Med       Date:  2021-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.